← Eichor
Condition: High Risk Patients Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: High Risk Patients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
Phase 2 · 1 location(s) · Ivan de Kouchkovsky, MD · NCT06384222Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk R
Phase 2 · 4 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07239245Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Phase 2 · 1 location(s) · University of Rochester · NCT05597345Renal Adjuvant MultiPle Arm Randomised Trial
Phase 3 · 35 location(s) · University College, London · NCT03288532Evaluating the Short-term Efficacy of Two Oscillation Techniques in Hypersecretive Mechanically Ventilated Patients
NA · 1 location(s) · Capital Medical University · NCT06675942Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Phase 1/Phase 2 · 1 location(s) · Indiana University · NCT06937866Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy
NA · 38 location(s) · University Hospital, Tours · NCT06966310A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patien
Phase 2/Phase 3 · 2 location(s) · Shanghai Jiao Tong University School of Medicine · NCT03258320Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2 · 3 location(s) · Tianjin Medical University Second Hospital · NCT07475403Nafamostat Efficacy in Phase 3 Registrational CRRT Study
NA · 10 location(s) · Talphera, Inc · NCT06150742The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk
Phase 4 · 1 location(s) · Brigham and Women's Hospital · NCT05152888Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program
NA · 1 location(s) · Fundació Sant Joan de Déu · NCT06431854To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients Wi
Phase 1/Phase 2 · 6 location(s) · RemeGen Co., Ltd. · NCT06378242[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
EARLY_Phase 1 · 2 location(s) · Beijing Tiantan Hospital · NCT07655869Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05776979Effects of UNICLA-A2 Dairy Products on Patients at High-risk of Colorectal Cancer Development
NA · 1 location(s) · Instituto de Investigación Sanitaria Aragón · NCT04824053Discontinuation Study
NA · 1 location(s) · University College Cork · NCT05866757Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-R
Phase 4 · 1 location(s) · CAMC Health System · NCT04279457Exercise in Patients With Hypermobile Joints and Knee Pain
NA · 2 location(s) · University of Southern Denmark · NCT06277401NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT06845319Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
Phase 2/Phase 3 · 1 location(s) · M.D. Anderson Cancer Center · NCT04708054High-intensity Intervals Versus Low-to-moderate-intensity Exercise Training in Patients With PAD
NA · 1 location(s) · Centre Hospitalier Universitaire Vaudois · NCT05612945Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03128879WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention
NA · 1 location(s) · Johns Hopkins University · NCT05950659Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients
NA · 1 location(s) · National and Kapodistrian University of Athens · NCT06780813Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functi
NA · 1 location(s) · University of Washington · NCT06710418MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myel
Phase N/A · 2 location(s) · MPN Research Foundation · NCT07362225Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patien
NA · 22 location(s) · Samsung Medical Center · NCT07009418Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding
Phase 4 · 1 location(s) · University of Florida · NCT07025148Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Phase 4 · 19 location(s) · AOP Orphan Pharmaceuticals AG · NCT06317805
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.